Medication Management Market Size, Share Analysis, Strategies, Revenue and Forecasts to 2023

 Market Insights

Market Research Future predicted that the global Medication Management system Market is set to reach the highest CAGR of 13.4% through the forecast period, 2018-2023.

Medication management focuses on improving medication use for the patient's condition. Interventions may include medication alignment, medication management, patient / family education about medications, and patient medication configuration simulations.

The growing geriatric population is one of the most important factors in the drug management market. Older people often have significant comorbidities that increase drug use and the risk of poor outcomes. According to a 2018 study published in Clinical Epidemiology, polypharmacy affects between 40% and 50% of older people in countries with high-income. Polypharmacy increases the risk of drug-related side effects in older people because more drugs are associated with a higher risk of harmful drug interactions. Several other factors, such as the emergence of funds in the healthcare sector and the need to reduce healthcare costs, are some of the drivers of the market.

However, the high costs of software implementation and service maintenance can hinder the market growth during the forecast period.

Regional Outlook

The United States has dominated the global drug management market. This growth can be ascribed to the rise in the elderly population and the presence of the main market players in the region.

Europe ranked second in 2017 due to the presence of developed economies such as the United Kingdom, Germany, France, and other countries in the region, which is an engine for market growth.

The Asia Pacific region is likely to see the fastest growth in 2017. Factors such as health technology sector growth, increasing market penetration in the region, and growing government support for foreign investment provide regional markets in the region. Asia Pacific.

In addition, the Middle East and Africa had the lowest share of the global drug management market due to the existence of low per capita income and poor economies, especially in the African region. The Middle East region is considered an important market for the Middle East and Africa region.

Market Segmentation

The global Medication management System market is segmented based on systems, services, delivery methods, and end-user.

The global system-based medication management market is divided into computerized physician order entry systems, clinical decision support systems, administration software, inventory management systems, automated dispensing systems, and assurance systems. Administration software segment is further classified as Bar Code Drug Delivery Software (BCMA) and Electronic Drug Management Software (eMAR). The automatic distributor's segment is further classified as centralized automated distribution systems and decentralized automated distribution systems (ADS). A centralized automated dosing system includes robots / dosing systems and automated carousels. The decentralized automated dispensing system (ADS) comprises automated decentralized unit dose metering systems, pharmacy-based decentralized automated dispensing systems, and service-based decentralized automated dispensing systems.

The services market segment is subdivided into point-of-care verification services and drug side effects monitoring.

The global market, on the basis of delivery mode, is divided into on-premise solutions, web-based solutions, and cloud-based solutions.

The market is segmented into pharmacies, hospitals, healthcare facilities, research institutes, and others, based on end-user.

 

Major Players

The leading players that are supporting the functioning of the global medication management market include General Electric Company, Siemens Ltd, Medical Information Technology, QuadraMed Affinity Corporation, Allscripts Healthcare Solutions, Cerner Corporation, Mckesson Corporation, Omnicell, Inc., Carefusion Corporation, Epic Systems Corporation, and Optum Inc.

Recent Updates

• Omnicell, Inc., a leading  of medication management solutions for healthcare and pharmacy systems, has announced that Mercy, one of five US healthcare systems for Oklahoma, Arkansas, Missouri, and Kansas, will take over the management of medication in your service network through its Omnicell's automation and intelligence solutions. Omnicell works with major healthcare systems, such as Mercy, and the company launches its vision for independent pharmacies, a step-by-step plan for developing a fully automated zero-error drug management infrastructure. Based on automation, data intelligence, and specialized services, the autonomous pharmacy will allow pharmacists, nurses, physicians, and pharmacist staff to focus on patient and physician satisfaction.

Read More @ https://www.marketresearchfuture.com/reports/medication-management-market-7187 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

Covid19 Impact on Hemophilia Treatment Market Analysis Revealing Key Drivers, Growth Trends and Competitive Analysis through 2023

 Hemophilia refers to an inherited genetic blood disorder which affects the ability of the blood to clot due to the lack of a specific protein required for blood clotting. As per the analysis of Market Research Future (MRFR), the global hemophilia treatment market is likely to post a CAGR of 6.10% over the forecast period of 2018-2023. The global hemophilia treatment market was valued at USD 11,257.21 in 2017 and is due to reach a valuation of USD 16,059.17 by the end of 2023. 

Get Latest Free Sample Copy @https://www.marketresearchfuture.com/sample_request/5688

The prevalence of hemophilia is found to be high across the globe, and it is in the backdrop of such high prevalence of hemophilia, the Global hemophilia treatment market is expanding steadily. The World Federation of Hemophilia estimates the number of people suffering from hemophilia in the US to be close to 17,000. 

An outlay of massive amounts by biotechnology companies and high government support for R&D activities has resulted in significant developments in recent years. Recombinant products have emerged as an alternative to plasma-derived products and consumers have demonstrated an increased inclination towards the use of recombinant products which can also be credited for the growth of the global hemophilia treatment market. Recombinant products, is derived from genetically engineered cells at are zero risks of contamination. 

On the downside, the market growth might be deterred by the high costs associated with hemophilia treatment which restricts the growth of the market in cost-sensitive markets. Hemophilia treatment involves a variety of technologically high-end products which limits the patient pool opting for treatment. 

Segmentation

The global hemophilia treatment market has been segmented based on type, treatment type, and end user. 

By type, the global hemophilia treatment market has been segmented into hemophilia A, hemophilia B, and hemophilia C. The hemophilia A segment is the largest segment and is expected to reach a valuation of USD 12,697.99 at a CAGR of 6.23% by the end of the forecast period. 

By treatment type, the global hemophilia treatment market has been segmented into Plasma-derived coagulation factor concentrate, Recombinant coagulation factor concentrates, Desmopressin, Antifibrinolytic agents, and Gene Therapy. The recombinant coagulation factor concentrates segment is likely to expand at the highest CAGR of 7.01% over the forecast period. 

By end user, the global hemophilia treatment market has been segmented into hospitals & clinics, research organizations, and others. The hospitals & clinics segment accounted for the largest share of USD 7594.66 in 2017 and is also anticipated to showcase the fastest growth over the forecast period. 

Regional Analysis

Geographically, the global hemophilia treatment market has been segmented into the Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA). The Americas account for the lion's share of the global hemophilia treatment market and is likely to maintain its lead over the forecast period. The growth of the Americas market can be attributed to the high occurrence of the disorder in the region coupled with growing expenditure on the healthcare sector. The presence of an established healthcare sector and towering support for R&D activities acts as a plus for the market growth. 

Europe holds the second largest share of the global hemophilia treatment market and exhibits similar growth pattern as that of the Americas. The Europe hemophilia treatment market is driven by high government support for research and development to develop advanced medical therapies. 

APAC is poised to showcase the highest growth rate of 8.38% over the forecast period. Prolific improvement in the healthcare sector coupled with high demand for advanced treatment options stimulates the growth of the APAC hemophilia treatment market. The presence of a large patient pool is also a co0ntributing factor. 

Competitive Landscape

The key players in the global hemophilia treatment market include F.Hoffmann-La Roche Ltd, Bayer AG, Baxter, Pfizer Inc, Sanofi, Novo Nordisk A/S, Shire, Kedrion, CSL Behring, Octapharma, Swedish Orphan Biovitrum AB, and Grifols International S.A. 

Read Complete Report @ https://www.marketresearchfuture.com/reports/hemophilia-treatment-market-5688

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

Global Growth On Diagnostic Electrocardiograph (ECG) Market Size, Share and Regional Analysis

 Diagnostic Electrocardiograph (ECG) Market Overview

Populations with heart-related disorders are increasing. Diagnostic electrocardiograph (ECG) is a device for observing the heart activity, which helps the observer record the behavior. Being a minimally invasive technique, it has gained a huge response from the practitioners are patients. The rapid development in diagnostic techniques and rising heart-related disorders due to unhealthy lifestyles and habits have boosted the market. Also, the rise in demand for early detection technologies has increased the usage and adoption of ECG.

Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/8787 

As the geriatric population increases, regular heart observation has required, which has propelled the market at much greater speeds. After observing ECG technology's capabilities, the healthcare facilities are rapidly adopting this technology, which has led to an increase in healthcare budgets and has increased the market's global share. Also, the companies are readily investing in the research & development programs to unfold new segments of this market, like the introduction of devices with maximum accuracy. 

Apart from the uses and features, the global diagnostic electrocardiograph market is facing friction from factors like struggling economic structures and scarcity of trained professionals, which has degraded the market's growth rates. This report will shed light on the competition, opportunities, drivers & restraints, and other factors affecting the local and global diagnostic electrocardiograph (ECG) market. The global market is expected to register nearly a 06 % annual growth rate during the survey. 

Diagnostic Electrocardiograph (ECG) Market division

The global diagnostic electrocardiograph (ECG) market is segmented into classes as follows:

The global diagnostic electrocardiograph market is segmented into stress ECG devices, smart ECG monitors, rest ECG devices, and others based on product types.

The global diagnostic electrocardiograph market divided into the single lead, 3 lead, 5 lead, and other devices based on lead type.

Based on end-users, the global diagnostic electrocardiograph market is segmented into hospitals, clinics, and others.

Diagnostic Electrocardiograph (ECG) Market Regional Classification

Diagnostic Electrocardiograph (ECG) has gained global adoption worldwide due to the demands for better healthcare technologies and increasing healthcare budgets globally. The Asia Pacific, North America, Europe, and the rest of the world are the major market studies for the global Diagnostic Electrocardiograph (ECG) market. The North American region is leading the market due to demands for better alternatives, well-established healthcare facilities, and other factors. On the other hand, the Asia Pacific region will file the fastest growth rate due to rapidly developing the healthcare system, rising government initiatives increasing research & development programs, demands for better healthcare alternates, vast population covers, rise in old age populations, and other factors.Industry News

The global diagnostic electrocardiograph market has become an important part of the healthcare system as the heart is the life o

Read Complete Report @ https://www.marketresearchfuture.com/reports/diagnostic-electrocardiograph-market-8787

f the human body and needs intensive care and monitoring. The authorities have reacted actively to these devices as they are capable of early detection of related disorders and are non-invasive, which has forced them to invest and increase the healthcare budgets. The global market is led by the North American region, followed by the European region, whereas the Asia Pacific region will register the highest growth rates.

NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com 

Top Leaders Focus On Diabetes Monitor Market Forecast to 2023

 Overview:

Diabetes monitoring is a type of testing that tries to detect the blood-glucose ratio to find out the concentration level. The process, in case of diabetes, involves piercing of the body part to receive a sample of the blood and then putting that on a chemically-active strip to understand the concentration level. The strip is disposable. These devices are known as diabetes monitor market. Other instruments are also available to check the urine sample or sweat sample. On the other hand, Abbott has launched one that requires no finger-pricking. 

FREE LATEST SAMPLE COPY OF “Diabetes Monitor Market Research Report- Global forecast till 2023”@ https://www.marketresearchfuture.com/sample_request/4781

The global market for diabetes monitoring can enjoy strong growth due to the growing investment in research and development. Hike in disposable income is also expected to support the global market by spurring the intake of the product. Innovation can play a pivotal role in taking the market ahead. 

Competitive Landscape:

A number of companies are expected to project strong growth for the global diabetes monitor market share These companies are Abbott Laboratories, Panasonic, F. Hoffmann-La Roche Ltd, Dexcom, Inc., Sanofi, Medtronic, LifeScan, Inc., and others. MRFR recorded their growth and profiled their moves for the market to understand the market route chart for the coming years in a better way. Their steps often rely on successful integration of various strategies that would not just solidify their market stance but would take the market ahead in the coming years. 

In September 2019, Sanofi announced that they have decided to collaborate with Abbott to launch a new diabetes monitoring technology that would integrate better quality glucose sensing and superior insulin delivery technologies, in order to facilitate better diabetes management. The device would adopt FreeStyle Libre technology. 

Segmentation:

The market study for global diabetes monitors relies on sample, type, component, and end-users for better analysis. The study includes factorial findings to support various details and provide better insights that can ensure better path selection for the coming years. 

By sample, the market for diabetes monitor can include blood samples, urine samples, sweat samples, and others. All these samples play an integral part in the correct measurement of diabetes. However, blood samples are quite popular. 

By type, the market for diabetes monitor includes continuous glucose monitors, point sample test-based glucose monitors, and enzyme-free sensor-based glucose monitors. The continuous glucose monitors segment includes re-usable sensor-based CGM, and disposable sensor-based CGM,

By components, the study includes glucose test strips, lancet, and sensors. The sensors segment comprises enzyme-based sensors and enzyme-free sensors

By end users, the report covers hospitals, diagnostic clinics, and home. All these segments are providing much traction. The simplicity of monitoring technology is giving traction to the home segment. 

Regional Analysis:

The Americas has maximum market domination. Of the two major regions, North America is providing substantial market traction due to its superior infrastructure, solid investment capacity, high tendency to include technologies and others. Various companies are also operating from the region that can trigger boost for the market. Also, the market is gaining strong grounds due to the increasing patient population. Government initiatives are also remarkable. In South America, Argentina and Brazil are showing substantial growth capacity but these two countries can only provide growth with solid investment from various global players. 

Europe is gaining substantial coverage due to the presence of several developed countries like France, the UK, Germany, Denmark, and others. Several countries from Northern Europe are showing strong potential. Governments are also making it mandatory to undergo several diabetes tests to ensure better safety provision for patients. Health insurances provide these compensations. 

The APAC market is expected to gain a notable hike due to the increasing participation in the region from several governments. The devices are also cost-effective, which helps the market in gaining remarkable grounds. Huge patient pool and hike in technology can also ensure better market growth. 

The Middle East and Africa may find the growth to be sluggish due to the presence of several weak economies.

OBTAIN RESEARCH REPORT DETAILS WITH Covid19 Impact on this @ https://www.marketresearchfuture.com/reports/diabetes-monitors-market-4781 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

Latest Research On Aromatherapy Market (2020-2023) | MRFR

The Aromatherapy Market is expected to exhibit a solid 6.18% CAGR over the forecast period from 2017 to 2023, according to the latest research report from Market Research Future (MRFR). The global aromatherapy market is expected to reach USD 4.3 billion by 2023, according to the MRFR report. The global aromatherapy market is profiled in great detail in the research report, providing readers with a comprehensive overview of the market through its historical growth trajectory, present conditions, and future growth prospects. The historical stats of the aromatherapy market are detailed in the report, in order to provide readers with a complete overview of the market’s historical growth trajectory. The historical stats provided in the report also give analysts a solid platform to base future projections about the market. Based on this platform, future projections for the aromatherapy market’s growth trajectory over the forecast period are provided in the report. The leading players in the global aromatherapy market are also profiled in the report in order to give readers a comprehensive analysis of the leading players in the global aromatherapy market. The major drivers and restraints affecting the global aromatherapy market are also profiled in the report to provide readers a comprehensive overview of what’s making the market tick and what is holding the market back.

Latest Free Sample PDF Available @ https://www.marketresearchfuture.com/sample_request/3241

Aromatherapy comprises the use of aromatic oils and other aromatic compounds for enhancing the psychological and physical well-being of the patient. It is a traditional form of medicine and is still widely practiced around the world for various complaints such as sleeplessness and stress. The growing prevalence of lifestyle conditions such as insomnia and stress is likely to be a major driver for the global aromatherapy market over the forecast period. Essential oils used in aromatherapy are also effective in curing the common cold and other breathing disorders. This is also likely to be a major driver for the global aromatherapy market due to the growing prevalence of breathing disorders due to the growing prevalence of pollution around the world.

On the other hand, the lack of universal guidelines for aromatherapy is likely to be a key restraint on the global aromatherapy market. Some products used in aromatherapy may have adverse effects if used in excess. For example, cineole essential oil is poisonous in excess and can cause various disorders such as nausea, vomiting, muscular weakness, and rapid heartbeat, among others. Aromatherapy also suffers from the lack of medical evidence to back up its use. This is also a key restraint against the global aromatherapy market.

Competitive Leaderboard:

Leading players in the global aromatherapy market include Neal’s Yard Remedies, NOW Foods, doTERRA, Zija International, Young Living, Tree of Life, Muji, Air Aroma, and Nu Skin.

Segmentation:

The global aromatherapy market is segmented on the basis of essential oil, equipment, application, therapeutic application, and region.

By essential oil, the global aromatherapy market is segmented into floral, citrus, green/vegetative, herbaceous/camphoraceous, spicy, and others.

By equipment, the global aromatherapy market is segmented into nebulizer diffuser, ultrasonic diffuser, and heat diffuser.

By application, the global aromatherapy market is segmented into topical, inhalation, and aerial diffusion.

By therapeutic application, the global aromatherapy market is segmented into relaxation and sleep, pain management, skin and hair care, and others. The skin and hair care segment dominates the global aromatherapy market and is likely to remain the leading revenue generator over the forecast period.

Regional Analysis:

North America is the leading regional market for aromatherapy due to the growing demand for aromatherapy in the U.S. The U.S. is the leading national market for aromatherapy. The growing prevalence of insomnia in the U.S. is likely to be a major driver for the global aromatherapy market over the forecast period.

Europe is also a major regional market for aromatherapy. Asia Pacific is likely to remain the fastest growing regional market for aromatherapy over the forecast period. China and India are likely to be important national markets for aromatherapy over the forecast period.

OBTAIN RESEARCH REPORT DETAILS WITH TOC @ https://www.marketresearchfuture.com/reports/aromatherapy-market-3241

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

 

Non-Alcoholic Steatohepatitis (NASH) Biomarkers Market 2023 | MRFR

 Global Non-Alcoholic Steatohepatitis (NASH) Biomarkers Market Report: Information by Disease Outlook, Type (Serum Biomarkers, Hepatic Fibrosis Biomarkers, Others), End User (Pharmaceutical Companies and CROs, Others) and Region­­ - Forecast till 2024

Market Overview 

NAFLD's diagnosis is of particular significance due to the chances of its moving to more severe stages. In addition, in early-stage diagnosis instances, the use of specific strategies such as growing physical exercise and dietary modification may avoid unpleasantness of the disease. Except in more severe stages of the disease, like non-alcoholic steatohepatitis (NASH), it's still necessary to detect it as soon as possible because of the risk for cirrhosis progression.

Biomarkers are important for testing and treatment approaches for fatty liver disease cases and for faster diagnosis of potentially life threatening NASH and NAFLD. This will allow for the diagnosis and treatment of disease using a clear biomarker blood test, thereby preventing a biopsy of the liver. Managing the inherent comorbidities that produce NASH syndrome is possible, and the natural history of this daunting disease should increase. Furthermore, biomarker approaches will interface work in biomedicine.

The global market for Non-alcoholic Steatohepatitis (NASH) Biomarkers Market is projected to witness a 20.92 percent CAGR and is expected to hit the US$1.960.4 million mark by 2024. The key factors that pave the way for the growth of the worldwide market for non-alcoholic steatohepatitis biomarkers are the expanding presence of NASH, growing need for non-invasive diagnostic testing and awareness-raising campaigns. On the opposite, the existence of stringent rules for the certification of biomarkers by the United States FDA is expected to slow the growth of the market during the forecast period.

Market Segmentation

The global market for non-alcoholic steatohepatitis biomarkers has been segmented on the basis of end users and type. Based on type, the market is segmented into Hepatic Fibrosis Biomarkers, Serum Biomarkers, and others. And by end user, the market segment covers CROs, pharmaceutical companies, and others. The study on the global market for non-alcoholic steatohepatitis biomarkers focuses on market value and size at corporate, local, and global levels. From a broader perspective, the study report portrays the total market size of non-alcoholic steatohepatitis biomarkers by examining existing market patterns, historical evidence and expectations for future development. Market revenue from various national markets has been applied to quantify the global market's total revenue. The study offers an outline of the solutions in the industry, and also demonstrates the pace of growth in the global market.

Regional Overview

Geographically, the global demand for non-alcoholic steatohepatitis biomarkers has been subdivided into MEA, Asia-Pacific, North America, Europe, and is sub-segmented into country level markets such as India, the United States, China, Japan, Australia, etc. The report provides comprehensive information from regional segments while covering local and global market size, regional market rivals, performance data, and statistics on exports and import. The study also discusses regional market patterns, trends, production and utilization rate of goods, revenue from the market sector, and the rate of growth. The report also covers the demand data from several industries and a wide range of opportunities present in the region that are expected to drive growth.

Global Non-Alcoholic Steatohepatitis Biomarkers Market, by Region

• Americas
  • North America
    • US
    • Canada
  • Latin America

• Europe
  • Western Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Western Europe
  • Eastern Europe

• Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific

• Middle East & Africa
  • Middle East
  • Africa

Industry News

Research has found a biomarker linked to the growth of non-alcoholic fatty liver disorder in human beings that could help doctors uncover early stages of the illness. The scientists also found that this biomarker, a protein classified as the 'neuronal regeneration-related protein', plays a critical role in controlling a mechanism that is now being investigated as a therapeutic choice for the condition in clinical trials.

Read More @ https://www.marketresearchfuture.com/reports/non-alcoholic-steatohepatitis-biomarkers-market-7984

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

Regional Analysis On Global Neurovascular Devices Market Forecast to 2023

 Global Neurovascular Devices Market Research Report: Product (Aneurysm Coiling & Embolization Devices, Support Device) Therapeutic Application (Hemorrhagic & Ischemic Strokes) End-User (Hospitals, Ambulatory Surgical Units) – Global Forecast Till 2023

Neurovascular devices are devices used in the treatment of neurovascular diseases such as brain aneurysm, arteriovenous malformations, and others. The global neurovascular devices market report by Market Research Future (MRFR) contains useful insights and in-depth analysis of the pivotal market variables affecting the industry. It contains estimations for the period of 2018 to 2023 (forecast period) and the impact of the COVID-19 virus on the market.

Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/5544

Market Scope

The global neurovascular Medical devices market is set to touch a value of USD 3,177.76 million by 2023. It is expected to register a CAGR of 8.8% over the forecast period. Development of products, approval by regulatory bodies, and demand for minimally invasive procedures are major factors driving market growth. The large healthcare expenditure of nations is an instance of the large potential for the market. The NHS, a government agency of the U.K. government, had spent close to USD 6.6 billion for the period of 2012-2013. The outbreak of the COVID-19 pandemic has led to efforts being put into the manufacture of ventilators and other equipment and putting a halt in production of neurovascular devices.

But high procedural costs and lack of skilled personnel can hamper the market growth.

Segmentation

The global neurovascular devices market is segmented on the basis of product, therapeutic application, and end-user.

On the basis of the product, the market is segmented into aneurysm coiling & embolization devices, cerebral balloon angioplasty and stenting systems, neurothrombectomy devices, and support device. The aneurysm coiling & embolization devices segment is sub-segmented into liquid embolic, embolic coils, and flow diversion devices. The embolic coils segment is further segmented into detachable coils, and pushable coils. Meanwhile, the neurothrombectomy devices segment is sub-segmented into retrieval systems and suction and aspiration devices. The support device segment is sub-segmented into microcatheters and microguidewires. Lastly, the cerebral balloon angioplasty and stenting systems segment is sub-segmented into carotid artery stents and embolic protection systems. The embolic protection systems segmented is further divided into balloon occlusion devices and distal filter devices.

On the basis of the therapeutic application, the market is divided into hemorrhagic stroke and ischemic strokes.

On the basis of the end-users, the market is segmented into hospitals & clinics, and ambulatory surgical units.

Regional Analysis

The Americas can dominate the global neurovascular devices market owing to increasing prevalence of neurovascular diseases like arteriovenous malformations (AVMs), brain aneurysm, and others. According to a study published in the Methodist DeBakey Cardiovascular Journal in 2014, about one million strokes occurred annually in the U.S. with 10% to 15% with the cause accounted to intracranial atherosclerotic disease. The inflated healthcare expenditure and presence of key players within the region can widen the scope of the market in the region.

Europe is the second-largest neurovascular devices market. This can be attributed to the presence of a well-developed healthcare sector and increasing prevalence of neurovascular diseases. According to the Neurological Alliance in 2014, neurological cases in England had reached 12.5 million. This is expected to fuel the demand for neurovascular devices.

APAC follows Europe and is touted to exhibit a robust CAGR over the forecast period. The large patient pool, medical tourism in India and China, and massive demand for minimally invasive surgeries are prime factors driving the regional market growth. On the other hand, the MEA has the least share of the global neurovascular devices market due to the presence of poor economy, especially in the Africa region.

Competition Outlook

1. L. Gore & Associates, Inc., Blockade Medical, LLC., MicroPort Scientific Corporation, Rapid Medical, Johnson & Johnson Services, Inc., Gynesonics, Medtronic, Secant Group, LLC, Medikit Co., Ltd., Penumbra, Inc., Sensome, Neuravi, Merit Medical Systems, Inc., Evasc, Delaware Corporation, TERUMO CORPORATION, Abbott, OxfordEndovascular, and Stryker are key players of the global neurovascular devices market.

Read More !! https://www.marketresearchfuture.com/reports/neurovascular-devices-market-5544

NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:                                    

Akash Anand                                                                        

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com